Submassive Pulmonary Embolism After Knee Surgery
58-year-old woman presents with abrupt dyspnea and pleuritic chest pain three days after arthroscopic knee surgery. HR 118, BP 104/66, RR 24, SpO2 92% on room air. ECG shows sinus tachycardia and T-wave inversion in V1–V4. Troponin is elevated; BNP is elevated. CT pulmonary angiography shows bilateral main pulmonary artery emboli with RV/LV ratio 1.4. She is not hypotensive and has no syncope. She has no prior bleeding. Renal function is normal. She is started on intravenous heparin.
1. How would you risk-stratify this patient, and what treatment escalation, if any, is indicated?
Read the worked answer
She has intermediate-high-risk (submassive) PE: normotensive but with RV dysfunction on CT and elevated troponin/BNP. This is not low-risk PE. She needs continuous monitoring, anticoagulation with LMWH or UFH, and careful volume management.
Routine systemic thrombolysis is not recommended for stable intermediate-high-risk PE because it increases major bleeding and intracranial hemorrhage without a clear mortality benefit. Catheter-directed thrombolysis or mechanical thrombectomy can be considered as rescue therapy if she develops hemodynamic deterioration, worsening RV failure, or refractory hypoxemia. If she becomes hypotensive, systemic thrombolysis is indicated unless contraindicated. Do not use vasodilators or diuretics aggressively; maintain preload. The judgment is to monitor and escalate rather than treat reflexively with lytics.
2. What is the role of IVC filter, thrombophilia testing, and duration of anticoagulation?
Read the worked answer
IVC filter is not indicated routinely. It is reserved for patients with an absolute contraindication to anticoagulation or recurrent PE despite therapeutic anticoagulation. Thrombophilia testing is not routine for a provoked PE after surgery; it can be considered in selected patients with unprovoked or recurrent thrombosis, young age, or family history, but results rarely change acute management.
Duration: this is a provoked PE by recent surgery, so 3 months of anticoagulation is standard if the provoking factor is transient and resolved. If she has persistent risk factors or unprovoked PE, extended anticoagulation should be considered. DOACs are an option after the acute phase, but in the acute setting with RV strain and possible need for intervention, LMWH or UFH is preferred. Avoid aspirin as monotherapy for VTE.